FIELD: experimental medicine.
SUBSTANCE: method involves introducing 0.07-0.08 ml of complete Freund adjuvant and subjecting animal organism to immobilization stress action for 1 h every day during a period from 14-th to 28-th day.
EFFECT: high reproducibility of the disease for investigating predisease-to-disease transition conditions.
2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF EXPERIMENTAL PSEUDORHEUMATISM MODELLING | 2007 | 
 | RU2351021C1 | 
| METHOD FOR CREATION BIOLOGICAL MODEL OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN EXPERIMENT | 2016 |  | RU2612843C1 | 
| METHOD FOR MODELING ARTHRITIS | 0 | 
 | SU1748174A1 | 
| AGENT FOR TREATING INFLAMMATORY DISEASES OF THE JOINTS | 2019 | 
 | RU2707278C1 | 
| BIOLOGICALLY ACTIVE AGENT EXHIBITING A LOCAL ANTI-INFLAMMATORY EFFECT IN ADJUVANT ARTHRITIS | 2021 | 
 | RU2771567C1 | 
| WATER-SOLUBLE TYROSINE DERIVATIVES HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2017 | 
 | RU2678563C1 | 
| TYROSINE HETEROCYCLIC AMIDES, HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2018 | 
 | RU2685505C1 | 
| PROCESS FOR SIMULATING RHEUMATOID ARTHRITIS | 0 | 
 | SU1098027A1 | 
| METHOD OF SIMULATING RHEUMATOID ARTHRITIS | 0 | 
 | SU764661A1 | 
| COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 | 
 | RU2701720C1 | 
Authors
Dates
2007-08-27—Published
2005-11-21—Filed